Neurocrine Biosciences (NBIX) Price to Sales (2009 - 2026)
Neurocrine Biosciences' Price to Sales was 3.88 in Q3 2026, down 25.6% from 5.22 a year earlier and down 23.5% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Price to Sales (2009 - 2026) Analysis & Trends
For FY2025, Price to Sales at Neurocrine Biosciences came in at 4.96, down 13.8% from FY2024.
- Price to Sales has now declined for three consecutive years.
- In earlier years, Price to Sales was 5.76 in FY2024 (-16.4%), 6.89 in FY2023 (-11.0%), 7.74 in FY2022 (+8.6%) and 7.13 in FY2021 (-16.8%).
- The Q3 2026 figure marks the lowest quarterly Price to Sales in data going back to Q1 2011.
- Compared with a year earlier, Price to Sales was higher in two of the last eight quarters, with an average decline of 14.8%.
- The best year-over-year quarter for Price to Sales over five years was Q2 2024 (growth of 19.1%); the worst was Q1 2025 (a decline of 35.2%).
- Per Business Quant data, NBIX's Price to Sales in the three quarters before Q3 2026 was 5.08 (Q2 2026), 4.27 (Q1 2026) and 4.96 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Neurocrine Biosciences | 17.13 Bn | 13.21 Bn | 1.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.88 |
| Jun 30, 2026 | 5.08 |
| Mar 31, 2026 | 4.27 |
| Dec 31, 2025 | 4.96 |
| Sep 30, 2025 | 5.22 |
| Jun 30, 2025 | 4.96 |
| Mar 31, 2025 | 4.54 |
| Dec 31, 2024 | 5.76 |
| Sep 30, 2024 | 5.20 |
| Jun 30, 2024 | 6.55 |
| Mar 31, 2024 | 7.00 |
| Dec 31, 2023 | 6.89 |
| Sep 30, 2023 | 6.19 |
| Jun 30, 2023 | 5.50 |
| Mar 31, 2023 | 6.17 |
| Dec 31, 2022 | 7.74 |
| Sep 30, 2022 | 7.35 |
| Jun 30, 2022 | 7.19 |
| Mar 31, 2022 | 7.41 |
| Dec 31, 2021 | 7.13 |
API Access
Neurocrine Biosciences Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();